| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac5c4697f61690ee45cc08d7a75d8531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_802b888ea9a67e468e397378436fa341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84b918d11b1a695fcfd44685b3a620be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ea532c12bef4473dd924282c4e50963
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec1428f6fc6519dd9049704a5a4dec85 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
| filingDate |
2011-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57f7863dcae11d8cfdc91f1a406d4018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6755a863e7675ef4472f090659dbd38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3957832d911ab546c6b2c5eba161beef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_089355955b6037dabfb6c808c3a629f0 |
| publicationDate |
2011-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011149964-A2 |
| titleOfInvention |
Methods for treating or preventing vascular graft failure |
| abstract |
The described invention provides pharmaceutical compositions and methods for treating or preventing vascular graft failure in a subject in need of such treatment, the method comprising administering a therapeutically effective amount of a composition comprising a polypeptide of amino acid sequence YARAAARQARAKALARQLGVAA (SEQ ID NO: 1) or a functional equivalent thereof, and a pharmaceutically acceptable carrier. The methods also are clinically useful for treating a pre-atherosclerotic intimal hyperplasia condition. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10562947-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9642888-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2696888-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9890200-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10500249-B2 |
| priorityDate |
2010-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |